Volatomics for Diagnosis and Risk Stratification of MASLD: A Proof-Of-Concept Study.
Journal:
Alimentary pharmacology & therapeutics
Published Date:
Jul 1, 2025
Abstract
BACKGROUND AND AIMS: Human breath contains numerous volatile organic compounds (VOCs) produced by physiological and metabolic processes or perturbed in pathological states. Electronic nose (eNose) technology has been extensively validated as a non-invasive diagnostic tool for respiratory disease. Using eNose-derived exhaled breath signals, we investigated whether it could discriminate patients with metabolic dysfunction-associated steatotic liver disease (MASLD) from healthy volunteers and identify patients at high risk of disease progression.